atacand 4 mg
tzamal bio-pharma ltd - candesartan cilexetil - tablets - candesartan cilexetil 4 mg - candesartan - candesartan - hypertension. treatment of patients with heart failure and impaired left ventricle systolic function ( left ventricular ejection fraction < or = 40 % ) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.
atacand 4 mg tablets
cheplapharm arzneimittel gmbh - candesartan cilexetil - tablet - 4 milligram(s) - angiotensin ii antagonists, plain; candesartan
atacand 4mg tablets
pco manufacturing ltd. - candesartan cilexetil - tablet - 4 milligram(s) - angiotensin ii antagonists, plain; candesartan
atacand 4mg tablets
imed healthcare ltd. - candesartan cilexetil - tablet - 4 milligram(s) - angiotensin ii antagonists, plain; candesartan
atacand
astrazeneca limited - candesartan cilexetil 4mg; ; - tablet - 4 mg - active: candesartan cilexetil 4mg excipient: carmellose calcium hyprolose lactose monohydrate macrogol 8000 magnesium stearate maize starch purified water - treatment of hypertension
atacand 4 mg tablets
astrazeneca ab - candesartan cilexetil - tablet - 4 milligram(s) - angiotensin ii antagonists, plain; candesartan
atacand 4 mg tablets
imbat limited - candesartan cilexetil - tablet - 4 milligram(s) - angiotensin ii antagonists, plain; candesartan
candesartan 4mg tablets
crescent pharma ltd - candesartan cilexetil - oral tablet - 4mg
atacand 8 mg
tzamal bio-pharma ltd - candesartan cilexetil - tablets - candesartan cilexetil 8 mg - candesartan - candesartan - hypertension. treatment of patients with heart failure and impaired left ventricle systolic function ( left ventricular ejection fraction < or = 40 % ) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.
atacand 16 mg
tzamal bio-pharma ltd - candesartan cilexetil - tablets - candesartan cilexetil 16 mg - candesartan - candesartan - hypertension. treatment of patients with heart failure and impaired left ventricle systolic function ( left ventricular ejection fraction < or = 40 % ) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.